• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed

    2/18/21 4:14:44 PM ET
    $NNOX
    Medical Electronics
    Health Care
    Get the next $NNOX alert in real time by email
    SC 13G 1 formsc13g.htm FORM SC 13G

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G
    Under the Securities Exchange Act of 1934

    (Amendment No. __)*

    Nano-X Imaging Ltd.
    (Name of Issuer)

    Ordinary Shares
    (Title of Class of Securities)

    M70700105
    (CUSIP Number)

    December 31, 2020
    (Date of Event Which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
     
     
    ☐
    Rule 13d-1(b)
     
     
    ☐
    Rule 13d-1(c)

     
    ☒
    Rule 13d-1(d)
     
    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
     
    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).



    CUSIP No. M70700105
     
    Page 2 of 5 Pages

    1
    NAMES OF REPORTING PERSONS
     
     
    Moshe Moalem
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     

     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    Israel
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
    3,948,670
     
     
     
     
    6
    SHARED VOTING POWER
     
     
    0
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
    3,948,670
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
    0
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    3,948,670
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
    8.6%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    IN
     
     
     
     
     

    CUSIP No. M70700105
     
    Page 3 of 5 Pages
     
    ITEM 1(a).
    NAME OF ISSUER
     
    Nano-X Imaging Ltd. (the “Issuer”).
     
    ITEM 1(b).          ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES
     
    Communications Center, Neve Ilan, Israel 9085000
     
    ITEM 2(a).
    NAME OF PERSONS FILING
     
    Moshe Moalem
     
    ITEM 2(b).
    ADDRESS OF PRINCIPAL BUSINESS OFFICE
     
    39 Shamgar St., Tel Aviv, Israel 6993592
     
    ITEM 2(c).
    CITIZENSHIP
     
    Israel
     
    ITEM 2(d).
    TITLE OF CLASS OF SECURITIES
     
    Ordinary shares of the Issuer
     
    ITEM 2(e).
    CUSIP NUMBER
     
    M70700105
     
    ITEM 3.
    If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
     

    (a)
    ☐
    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
     

    (b)
    ☐
    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
     

    (c)
    ☐
    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
     

    (d)
    ☐
    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);
     

    (e) ☐
    An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
     

    (f)
    ☐
    An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
     

    (g)
    ☐
    A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
     

    (h)
    ☐
    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
     

    (i)
    ☐
    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
     

    (j)
    ☐
    A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
     

    (k)
    ☐
    Group, in accordance with § 240.13d-1(b)(1)(ii)(K).
     

    CUSIP No. M70700105
     
    Page 4 of 5 Pages
     
    ITEM 4.
    OWNERSHIP
     

    (a)
    Amount beneficially owned: 3,948,670 ordinary shares
     

    (b)
    Percent of class: 8.6%
     
    (c)
     

    (i)
    Sole power to vote or direct the vote: 3,948,670 ordinary shares
     

    (ii)
    Shared power to vote or direct the vote: 0
     

    (iii)
    Sole power to dispose or to direct the disposition of: 3,948,670 ordinary shares
     

    (iv)
    Shares power to dispose or to direct the disposition of: 0
     
    ITEM 5.
    OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
     
    Not applicable.
     
    ITEM 6.
    OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
     
    Not applicable.
     
    ITEM 7.
    IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON
     
    Not applicable.
     
    ITEM 8.
    IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
     
    Not applicable.
     
    ITEM 9.
    NOTICE OF DISSOLUTION OF GROUP
     
    Not applicable.
     
    ITEM 10.
    CERTIFICATION
     
    Not applicable.
     

    CUSIP No. M70700105
     
    Page 5 of 5 Pages
     
    SIGNATURES

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

      DATE:
    February 18, 2021
         
     
    /s/ MOSHE MOALEM
         
        



    Get the next $NNOX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NNOX

    DatePrice TargetRatingAnalyst
    1/6/2025$23.00Buy
    D. Boral Capital
    9/8/2023$14.50Buy
    Alliance Global Partners
    1/5/2023$21.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $NNOX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    D. Boral Capital initiated coverage on Nano-X Imaging with a new price target

    D. Boral Capital initiated coverage of Nano-X Imaging with a rating of Buy and set a new price target of $23.00

    1/6/25 9:02:00 AM ET
    $NNOX
    Medical Electronics
    Health Care

    Alliance Global Partners initiated coverage on Nano-X Imaging with a new price target

    Alliance Global Partners initiated coverage of Nano-X Imaging with a rating of Buy and set a new price target of $14.50

    9/8/23 9:14:06 AM ET
    $NNOX
    Medical Electronics
    Health Care

    Cantor Fitzgerald initiated coverage on Nano-X Imaging with a new price target

    Cantor Fitzgerald initiated coverage of Nano-X Imaging with a rating of Overweight and set a new price target of $21.00

    1/5/23 7:46:34 AM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nanox Announces Multi-Segment Healthcare Collaboration with Monarch Medical Management to Expand Access to Advanced Medical Imaging

    Collaboration spans workers' compensation, nursing homes, and outpatient clinics PETACH TIKVA, Israel, Sept. 18, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced a collaboration between its U.S. subsidiary Nanox Impact Inc. and Monarch Medical Management and Billing LLC ("Monarch"), an experienced healthcare management organization with established relationships across industry sectors, to deploy Nanox's advanced imaging solutions across multiple healthcare segments including workers' compensation, nursing home facilities, and outpatient clinics. As part of the collaboration, Nan

    9/18/25 8:00:07 AM ET
    $NNOX
    Medical Electronics
    Health Care

    Nanox Announces Second Quarter of 2025 Financial Results and Provides Business Update

    Management to host conference call and webcast Tuesday, August 12, 2025 at 8:30 AM ET Company continued to grow Nanox.ARC installed base and is on track to meet its year-end system deployment target PETAH TIKVA, Israel, Aug. 12, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced results for the second quarter ended June 30, 2025 and provided a business update. Recent Highlights: Generated $3.0 million in revenue in the second quarter of 2025, compared to $2.7 million in the second quarter of 2024.Grew Nanox.ARC system sales funnel exponentially in the quarter.The Company notified the FD

    8/12/25 8:00:00 AM ET
    $NNOX
    Medical Electronics
    Health Care

    Nanox to Report Second Quarter 2025 Financial Results on August 12, 2025

    PETACH TIKVA, Israel, Aug. 01, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended June 30, 2025, before market open on Tuesday, August 12, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q2 2025 Conference Call. The live webcast of the conference call may be accessed by

    8/1/25 4:05:00 PM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CFO Daniel Ran bought $3,650 worth of Ordinary shares (1,000 units at $3.65), increasing direct ownership by 17% to 6,950 units (SEC Form 4)

    4 - Nano-X Imaging Ltd. (0001795251) (Issuer)

    9/5/25 5:41:26 PM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CFO Daniel Ran bought $3,650 worth of Ordinary shares (1,000 units at $3.65), increasing direct ownership by 17% to 6,950 units (SEC Form 4)

    4 - Nano-X Imaging Ltd. (0001795251) (Issuer)

    9/5/25 5:41:26 PM ET
    $NNOX
    Medical Electronics
    Health Care

    New insider Daniel Ran claimed ownership of 5,950 units of Ordinary Shares (SEC Form 3)

    3 - Nano-X Imaging Ltd. (0001795251) (Issuer)

    9/5/25 2:11:14 PM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    Leadership Updates

    Live Leadership Updates

    View All

    Nanox Announces Appointment of Medical Executive Moshe Shtengel as Chief Business Officer

    NEVE ILAN, Israel, May 03, 2021 (GLOBE NEWSWIRE) -- NANOX IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, announced today the appointment of Moshe Shtengel as Chief Business Officer, effective May 2, 2021. Mr. Shtengel joins Nanox from Tuttnauer, a global manufacturer of sterilizers and infection control systems for medical institutions, where he served as Vice President of Global Sales, Marketing and Products. "Moshe is an extremely seasoned sales and business development executive with a proven track record of success and leadership in the medical field," stated Ran Poliakine, Chairman and Chief Executive Officer of Nanox. "As we

    5/3/21 8:00:00 AM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    Financials

    Live finance-specific insights

    View All

    Nanox Announces Second Quarter of 2025 Financial Results and Provides Business Update

    Management to host conference call and webcast Tuesday, August 12, 2025 at 8:30 AM ET Company continued to grow Nanox.ARC installed base and is on track to meet its year-end system deployment target PETAH TIKVA, Israel, Aug. 12, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced results for the second quarter ended June 30, 2025 and provided a business update. Recent Highlights: Generated $3.0 million in revenue in the second quarter of 2025, compared to $2.7 million in the second quarter of 2024.Grew Nanox.ARC system sales funnel exponentially in the quarter.The Company notified the FD

    8/12/25 8:00:00 AM ET
    $NNOX
    Medical Electronics
    Health Care

    Nanox to Report Second Quarter 2025 Financial Results on August 12, 2025

    PETACH TIKVA, Israel, Aug. 01, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended June 30, 2025, before market open on Tuesday, August 12, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q2 2025 Conference Call. The live webcast of the conference call may be accessed by

    8/1/25 4:05:00 PM ET
    $NNOX
    Medical Electronics
    Health Care

    Nanox Announces First Quarter 2025 Financial Results and Provides Business Updates

    PETACH TIKVA, Israel, May 22, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced results for the first quarter ended March 31, 2025, and provided a business update. Recent Highlights: Generated $2.8 million in revenue in the first quarter of 2025, compared to $2.6 million in the first quarter of 2024.Received 510(k) clearance from the FDA for the Nanox.ARC X, its updated multi-source digital Tomosynthesis system.Signed multiple commercial agreements to market the Nanox.ARC and the Nanox.AI solutions. "Since the beginning of 2025, Nanox has made consistent progress marketing our full end-

    5/22/25 8:00:00 AM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by NANO-X IMAGING LTD (Amendment)

    SC 13G/A - Nano-X Imaging Ltd. (0001795251) (Subject)

    3/7/24 12:29:51 PM ET
    $NNOX
    Medical Electronics
    Health Care

    SEC Form SC 13G filed by NANO-X IMAGING LTD

    SC 13G - Nano-X Imaging Ltd. (0001795251) (Subject)

    2/6/24 9:36:34 AM ET
    $NNOX
    Medical Electronics
    Health Care

    SEC Form SC 13G/A filed by NANO-X IMAGING LTD (Amendment)

    SC 13G/A - Nano-X Imaging Ltd. (0001795251) (Subject)

    2/14/23 4:15:16 PM ET
    $NNOX
    Medical Electronics
    Health Care

    $NNOX
    SEC Filings

    View All

    SEC Form 6-K filed by NANO-X IMAGING LTD

    6-K - Nano-X Imaging Ltd. (0001795251) (Filer)

    8/12/25 8:05:17 AM ET
    $NNOX
    Medical Electronics
    Health Care

    SEC Form 6-K filed by NANO-X IMAGING LTD

    6-K - Nano-X Imaging Ltd. (0001795251) (Filer)

    5/22/25 8:05:17 AM ET
    $NNOX
    Medical Electronics
    Health Care

    SEC Form 6-K filed by NANO-X IMAGING LTD

    6-K - Nano-X Imaging Ltd. (0001795251) (Filer)

    4/17/25 8:40:02 AM ET
    $NNOX
    Medical Electronics
    Health Care